An international committee of experts will release an interim report in early 2025 outlining criteria for diagnosing ...
After years of rising obesity rates in the US, the numbers dipped slightly during 2023, though experts disagree about the ...
The FDA also recommends that prescribed users reduce their caloric intake and increase their exercise The weight loss drug ...
Millions of obese Americans would get access to popular weekly injectables that would help them shed pounds quickly if a $ 35 billion proposal from the Biden administration is blessed by President ...
"FDA is aware that some patients and health care professionals may look to unapproved versions of GLP-1 drugs, including ...
The weight loss medication tirzepatide (Mounjaro and Zepbound) is no longer in shortage, according to the FDA. Access to ...
GLP-1 receptor agonists, which can cost around $1,300 a month, have caused an increase in premiums that “affect all members, ...
Among the many newcomers to the business of weight-loss drugs is Hims & Hers, an American e-pharmacy better known for hawking ...
The effects that a pause may have on your body may depend on why you're taking the medication in the first place.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback